Cargando…
Increased Interleukin-6 Activity Associated with Painful Chemotherapy-Induced Peripheral Neuropathy in Women after Breast Cancer Treatment
Accumulating evidence suggests that neural-immune interactions are involved in the development of painful chemotherapy-induced peripheral neuropathy, particularly through the increased release of proinflammatory cytokines. The purpose of this study was used to evaluate levels of interleukin [IL]-6 a...
Autor principal: | Starkweather, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168945/ https://www.ncbi.nlm.nih.gov/pubmed/21994811 http://dx.doi.org/10.1155/2010/281531 |
Ejemplares similares
-
Chemotherapy-induced peripheral neuropathy
por: Zhang, Xia, et al.
Publicado: (2017) -
Chemotherapy‐induced peripheral neuropathy increases nontraumatic fracture risk in breast cancer survivors
por: McNeish, Brendan L., et al.
Publicado: (2021) -
Morning Chronotype Decreases the Risk of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer
por: Son, Kyung-Lak, et al.
Publicado: (2022) -
Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer
por: Ben-Horin, Idan, et al.
Publicado: (2017) -
Review of a Study of Duloxetine for Painful Chemotherapy-Induced Peripheral Neuropathy
por: Wickham, Rita
Publicado: (2013)